Genomics, a leader in single cell and spatial genomics tools, reported a notable insider sale amid ongoing sector innovation.
Precision medicine company CareDx and 10x Genomics have partnered to launch ImmuneScape, a multiomics program to improve the understanding of transplant organ rejection and variability in patient ...
If you are trying to work out whether 10x Genomics at around US$20.92 is still good value or already pricing in a lot of optimism, it helps to break the story into simple numbers first. The stock has ...
During the last three months, 11 analysts shared their evaluations of 10x Genomics (NASDAQ:TXG), revealing diverse outlooks from bullish to bearish. The following table encapsulates their recent ...
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, and the A*STAR Genome Institute of Singapore (A*STAR GIS), today announced a research collaboration for the Target ...
Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded ...
I would now like to turn the conference over to Cassie Corneau, Senior Director, Investor Relations and Strategic Finance. You may begin. Thank you. And good afternoon, everyone. Earlier today, 10X ...
StockStory.org on MSN
The 5 most interesting analyst questions from 10x Genomics’s Q1 earnings call
Genomics' first quarter results were met with a negative market reaction, despite exceeding Wall Street’s revenue and ...
10x Genomics says it eliminated 8% of its workforce—about 100 jobs—as part of a company effort to cut $50 million in costs and better reflect strategic priorities that include addressing the uncertain ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
10x Genomics (TXG) closed the last trading session at $20, gaining 1.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results